Ovarian epithelial tumors and reproductive factors: a systematic review

被引:65
作者
Schueler, Susanne [1 ]
Ponnath, Marvin [1 ]
Engel, Joerg [1 ]
Ortmann, Olaf [1 ]
机构
[1] Univ Regensburg, Caritas Hosp St Josef, D-93053 Regensburg, Germany
关键词
Epithelial ovarian tumors; Ovarian cancer; Borderline ovarian tumors; Reproductive factors; Endocrine factors; Age at menarche; Age at menopause; Parity; Infertility; PCO syndrome; Oral contraception; Menopausal hormone therapy; Fertility treatment; HORMONE REPLACEMENT THERAPY; GONADOTROPIN-RELEASING-HORMONE; ORAL-CONTRACEPTIVE USE; HUMAN CHORIONIC-GONADOTROPIN; LIFETIME OVULATORY CYCLES; GRADE SEROUS CARCINOMA; STATES CASE-CONTROL; CANCER CELL-LINE; RISK-FACTORS; GROWTH-FACTOR;
D O I
10.1007/s00404-013-2784-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose The aim of this systematic review is to summarize the current knowledge about the etiology and pathogenesis of borderline tumors ovarian cancer with special emphasis on the role of endocrine treatments and reproductive factors to establish a foundation for future studies. Methods We performed a systematic review on the relation between ovarian epithelial tumors (OET) and reproductive factors using the keywords: ovarian cancer, ovarian tumor, ovarian borderline tumor, age at menarche, age at menopause, parity, infertility, PCO syndrome, oral contraception, menopausal hormone therapy, fertility treatment. Totally, 3,290 abstracts were scanned for their relevance in this publication and 127 were finally included. Results The incidence of ovarian epithelial cancer and ovarian borderline tumors is influenced by certain reproductive factors. The strongest protective effects are conferred by parity and use of oral contraceptive pills. Recent molecular biologic and histopathologic studies prove that OET represent a diverse group of tumors, each histologic type with a different genetic background. This is at least partly reflected in epidemiologic and clinical studies showing different risk modulating effects of reproductive factors and endocrine therapies on OET. Conclusions The etiology and pathogenesis of ovarian cancer are still not fully understood. None of the so far proposed hypothesis on the development of OET can fully account for the epidemiologic and clinical findings in the context of reproductive factors and OET development. Further research approaches are warranted and need to put more weight on the clinical and genetical diversity of OET to yield a more detailed insight into their pathogenesis.
引用
收藏
页码:1187 / 1204
页数:18
相关论文
共 251 条
  • [21] GONADOTROPIN-RELEASING-HORMONE AGONIST SUPPRESSION OF OVARIAN TUMORIGENESIS IN MICE OF THE W-X/W-V GENOTYPE
    BLAAKAER, J
    BAEKSTED, M
    MICIC, S
    ALBRECTSEN, P
    RYGAARD, J
    BOCK, J
    [J]. BIOLOGY OF REPRODUCTION, 1995, 53 (04) : 775 - 779
  • [22] Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
    Bonome, T
    Lee, JY
    Park, DC
    Radonovich, M
    Pise-Masison, C
    Brady, J
    Gardner, GJ
    Hao, K
    Wong, WH
    Barrett, JC
    Lu, KH
    Sood, AK
    Gershenson, DM
    Mok, SC
    Birrer, MJ
    [J]. CANCER RESEARCH, 2005, 65 (22) : 10602 - 10612
  • [23] RISK-FACTORS FOR OVARIAN-CANCER - A CASE CONTROL STUDY
    BOOTH, M
    BERAL, V
    SMITH, P
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (04) : 592 - 598
  • [24] Follicle Stimulating Hormone Receptor in Ovarian Surface Epithelium and Epithelial Ovarian Cancer
    Bose, Chinmoy K.
    [J]. ONCOLOGY RESEARCH, 2008, 17 (05) : 231 - 238
  • [25] Relationship between postmenopausal hormone replacement therapy and ovarian cancer
    Bosetti, C
    Negri, E
    Franceschi, S
    Trichopoulos, D
    Beral, V
    La Vecchia, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (24): : 3089 - 3089
  • [26] Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study
    Braem, M. G. M.
    Onland-Moret, N. C.
    van den Brandt, P. A.
    Goldbohm, R. A.
    Peeters, P. H. M.
    Kruitwagen, R. F. P. M.
    Schouten, L. J.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 172 (10) : 1181 - 1189
  • [27] Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines:: Down-regulation of ER-β in neoplastic tissues
    Brandenberger, AW
    Tee, MK
    Jaffe, RB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 1025 - 1028
  • [28] Ovarian cancer risk associated with varying causes of infertility
    Brinton, LA
    Lamb, EJ
    Moghissi, KS
    Scoccia, B
    Althuis, MD
    Mabie, JE
    Westhoff, CL
    [J]. FERTILITY AND STERILITY, 2004, 82 (02) : 405 - 414
  • [29] CANCER RISK AFTER EVALUATION FOR INFERTILITY
    BRINTON, LA
    MELTON, LJ
    MALKASIAN, GD
    BOND, A
    HOOVER, R
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (04) : 712 - 722
  • [30] Ovarian cancer risk after the use of ovulation-stimulating drugs
    Brinton, LA
    Lamb, EJ
    Moghissi, KS
    Scoccia, B
    Althuis, MD
    Mabie, JE
    Westhoff, CL
    [J]. OBSTETRICS AND GYNECOLOGY, 2004, 103 (06) : 1194 - 1203